Digital Protein Detection in Bulk Solutions.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
25 Oct 2022
Historique:
received: 24 07 2022
accepted: 21 09 2022
entrez: 31 10 2022
pubmed: 1 11 2022
medline: 1 11 2022
Statut: epublish

Résumé

Quick and accurate molecular diagnostics in protein detection can greatly benefit medicine in disease diagnosis and lead to positive patient outcomes. However, specialized equipment used in clinical laboratories often comes with trade-offs between operation and function serving a single role for very specific needs. For example, to achieve high analytical sensitivity and specificity, instruments such as high-performance liquid chromatography and/or liquid chromatography-mass spectrometry use a complex instrument design and require thorough training of the users. On the other hand, simple tests such as protein detection in urinary tract infection using dip-stick assays provide very quick results but suffer from poor analytical sensitivity. Here, we present an application study for the 3D particle counter technology, which is based on optical confocal detection in order to scan large sample volumes (0.5-3 mL) in glass cuvettes, that aims to close the gap between analytical sensitivity and turnover assay time and simplify protein detection by adopting bead-based immunoassays. Combining the 3D particle counter technology with bead-based immunoassays, a subpicomolar limit of detection-ranging from 119 to 346 fM-was achieved within 3.5-hour assay time for recombinant mouse interleukin 6 detection. As an alternative instrument to a flow cytometer, the 3D particle counter takes advantages of bead-based immunoassays and provides unique accessibility and flexibility for users.

Identifiants

pubmed: 36312374
doi: 10.1021/acsomega.2c04666
pmc: PMC9608401
doi:

Types de publication

Journal Article

Langues

eng

Pagination

37714-37723

Informations de copyright

© 2022 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare the following competing financial interest(s): W.Z. is a cofounder of Velox Biosystems Inc., Amberstone Biosciences Inc., and Arvetas Biosciences Inc.

Références

J Immunol. 1989 Dec 15;143(12):3949-55
pubmed: 2592764
Lab Chip. 2019 Mar 13;19(6):993-1005
pubmed: 30735225
Proc Natl Acad Sci U S A. 1985 Aug;82(16):5490-4
pubmed: 2410927
ACS Sens. 2020 Oct 23;5(10):3037-3042
pubmed: 32988208
J Med Microbiol. 2020 Jan;69(1):52-62
pubmed: 31846419
Anal Chem. 2016 Jul 19;88(14):7123-9
pubmed: 27322525
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6367-71
pubmed: 2474833
Nat Protoc. 2007;2(8):1918-30
pubmed: 17703203
Analyst. 2015 Sep 21;140(18):6277-82
pubmed: 26270328
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10113-9
pubmed: 10954739
ACS Nano. 2013 Jul 23;7(7):5955-64
pubmed: 23805985
Nat Biotechnol. 2010 Jun;28(6):595-9
pubmed: 20495550
Diagnostics (Basel). 2015 May 19;5(2):200-9
pubmed: 26854149
Crit Rev Biotechnol. 2017 Mar;37(2):163-176
pubmed: 26767547
J Infect Dis. 2015 Aug 15;212(4):585-95
pubmed: 25722296
EMBO J. 1986 Oct;5(10):2529-37
pubmed: 3023045
Proc Natl Acad Sci U S A. 2013 May 7;110(19):E1761-70
pubmed: 23610432
N Engl J Med. 2021 Apr 22;384(16):1491-1502
pubmed: 33631065
EMBO J. 1994 Mar 1;13(5):1189-96
pubmed: 8131749
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7152-6
pubmed: 6164058
J Immunol Methods. 1989 Dec 20;125(1-2):279-85
pubmed: 2558138
J Histochem Cytochem. 1979 Jan;27(1):36-43
pubmed: 220325
Front Immunol. 2021 Dec 02;12:747324
pubmed: 34925323
Ann Surg. 1992 Apr;215(4):356-62
pubmed: 1558416
Anal Biochem. 2016 Jun 15;503:11-20
pubmed: 27019152
Meas Sci Technol. 2013 Jun 1;24(6):65702
pubmed: 24039347
Nature. 1988 Mar 3;332(6159):83-5
pubmed: 3258060
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Biomed Opt Express. 2019 Feb 12;10(3):1223-1233
pubmed: 30891341
Arthritis Rheum. 2005 Jun;52(6):1700-10
pubmed: 15934068
Lab Chip. 2020 Feb 7;20(3):477-489
pubmed: 31872202
Arthritis Rheum. 2003 Jun;48(6):1521-9
pubmed: 12794819
Nat Commun. 2014 Nov 13;5:5427
pubmed: 25391809

Auteurs

Sungjun Beck (S)

Department of Biological Chemistry, University of California, Irvine, Irvine, California 92697, United States.

Donghae Shin (D)

Department of Biological Chemistry, University of California, Irvine, Irvine, California 92697, United States.

Sun Jin Kim (SJ)

Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, California 92697, United States.

Per Niklas Hedde (PN)

Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, California 92697, United States.
Laboratory for Fluorescence Dynamics, University of California, Irvine, Irvine, California 92697, United States.
Beckman Laser Institute & Medical Clinic, University of California, Irvine, Irvine, California 92697, United States.

Weian Zhao (W)

Department of Biological Chemistry, University of California, Irvine, Irvine, California 92697, United States.
Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, California 92697, United States.
Institute for Immunology, University of California, Irvine, Irvine, California 92697, United States.
Sue and Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, California 92697, United States.
Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, California 92697, United States.
Edwards Life Sciences Center for Advanced Cardiovascular Technology, University of California, Irvine, Irvine, California 92697, United States.
Department of Biomedical Engineering, University of California, Irvine, Irvine, California 92697, United States.

Classifications MeSH